Related Experiment Video

Updated: Jun 15, 2026

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

A call to arms: using RNAi screening to improve oncolytic viral therapy

D J Mahoney1, D F Stojdl

  • 1Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON K1H 8L1, Canada.

Cytokine & Growth Factor Reviews
|March 9, 2010
PubMed

Insights

Oncolytic virus therapy (OVT) shows promise for cancer treatment but faces limitations. RNA interference (RNAi) screening can identify host factors to improve OVT effectiveness against resistant tumors.

Area of Science:

  • Oncology
  • Virology
  • Genetics

Background:

  • Oncolytic virus therapy (OVT) is a promising cancer treatment modality with significant pre-clinical success.
  • Clinical trials are underway, but OVT efficacy is limited by tumor-specific resistance mechanisms.
  • The molecular basis for OVT resistance in certain cancer cells remains largely uncharacterized.

Purpose of the Study:

  • To explore the application of RNA interference (RNAi) screening for understanding host-virus interactions.
  • To identify host factors that impede oncolytic virus replication and efficacy.
  • To propose RNAi screening as a method to overcome barriers in oncolytic virus therapy.

Main Methods:

  • Genome-wide RNAi screens are utilized to systematically interrogate host cell functions.
  • RNAi screening is applied to study host-pathogen interactions, specifically in the context of virology.
  • Review and proposal of RNAi screening methodologies for oncolytic virotherapy research.

Main Results:

  • RNAi technology enables large-scale genetic screens to uncover functional gene roles.
  • Previous RNAi screens have provided insights into host-virus interactions.
  • This work highlights the potential of RNAi to address OVT limitations.

Conclusions:

  • Understanding the molecular mechanisms of OVT resistance is crucial for therapeutic advancement.
  • RNAi screening offers a powerful tool to dissect host factors influencing oncolytic virus efficacy.
  • Systematic genetic interrogation via RNAi can guide the development of more effective oncolytic virus therapies.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...